Test kits for radioimmunotherapy

AntiRat CD152 PE(Clone WKH 203 ,Mse IgG1 )50ug

AntiRat CD4 PE(Clone W3/25,Mse IgG1)50ug

AntiRat CD152 Pure(Clone WKH 203 ,Mse IgG1 )250ug

AntiRat CD4 Pure(Clone W3/25,Mse IgG1)250ug

A full antagonist of RXR that demonstrates potent, nanomolar binding affinity does not affect the corepressor interaction capacity of the RAR&alpha subunit in the RAR-RXR heterodimer configuration.

An immunomodulatory compound that inhibits inflammatory antigen presentation both in vitro and in preclinical in vivo models of autoimmune diseases targets macrophages, reducing the production of the proinflammatory mediators TNF-&alpha,

A multi-target inhibitor that potently blocks EGFR and HER2 (IC₅₀s = 2.4 and 16.

kb NB 142-70 is a selective inhibitor of protein kinase D (PKD) with IC₅₀ values of 28.3, 58.

Antigen: synthetic peptide from human FABP3 amino acids 44-55 Host: mouse Cross Reactivity:(+) human and rat FABP3, (&minus) mouse FABP3, other species not tested Application(s): WB (1:200 dilution) other applications not tested

A selective inhibitor of diacylglycerol lipase (IC₅₀ = 4 &microM) that demonstrates relatively weak inhibition of phospholipases A2 and C elevates the concentration of diacylglycerol, which leads to activation of PKC.

A non-steroidal androgen receptor antagonist (IC50 = 36 nM) reduces the efficiency of nuclear translocation of the androgen receptor and impairs both its binding to DNA and the recruitment of coactivators.

A selective inhibitor of NUAK1 and NUAK2 (IC₅₀s = 20 and 100 nM, respectively) inhibits the phosphorylation of the NUAK1 substrate MYPT1 at Ser445 inhibits proliferation and migration of mouse embryonic fibroblasts and U2OS cells at 10